Beaudeux J L, Peynet J, Flourie F, Keddad K, Delattre J, Rousselet F, Legrand A
Laboratoire Central de Biochimie, Hôpital Lariboisière, Paris, France.
Clin Biochem. 1994 Feb;27(1):7-11. doi: 10.1016/0009-9120(94)90004-3.
We compared the lipoprotein(a) [Lp(a)] levels in 32 icteric sera determined both by an electroimmunodiffusion assay (EIA), using the Hydragel Lp(a) kit (Sebia, France) and by two immunonephelometric assays, one on a Behring Nephelometer Analyzer (BNA), using antiserum from immunofrance, and the other on a Beckman analyzer (Array), using antiserum from Dako (Denmark). With the EIA assay, the Lp(a) level was 0.09 +/- 0.09 (mean +/- SD in g/L), with the BNA assay, 1.01 +/- 1.51 and with the Array assay, 0.05 +/- 0.05. Sample blanks values (0.76 +/- 1.28 g/L) demonstrated that the high Lp(a) levels obtained in the BNA assay are caused by nonspecific precipitation. Analysis of the precipitate indicated the presence of Lipoprotein X, an abnormal lipoprotein that appears in the serum of patients with obstructive jaundice or with lecithin-cholesterol acyltransferase deficiency. The precipitant seems to be polyethyleneglycol (PEG) that was added to the reaction medium in both the BNA and the Array assays to stabilize the Lp(a)-anti Lp(a) immune complex. In the Array assay, interference by this nonspecific precipitation is eliminated by preliminary centrifugation of the diluted sample. However, coprecipitation of Lp(a) could occur during this step. Consequently, the results of Lp(a) measurement in serum from patients with hepatobiliary diseases should be interpreted with caution when immunonephelometric assays are used with a medium containing PEG.
我们比较了32份黄疸血清中的脂蛋白(a)[Lp(a)]水平,分别采用法国Sebia公司的Hydragel Lp(a)试剂盒通过电免疫扩散测定法(EIA)、以及两种免疫比浊法进行测定。一种免疫比浊法是在拜耳比浊分析仪(BNA)上,使用来自Immunofrance公司的抗血清;另一种是在贝克曼分析仪(Array)上,使用来自丹麦达科公司的抗血清。采用EIA测定法时,Lp(a)水平为0.09±0.09(均值±标准差,单位:g/L);采用BNA测定法时,为1.01±1.51;采用Array测定法时,为0.05±0.05。样本空白值(0.76±1.28 g/L)表明,BNA测定法中获得的高Lp(a)水平是由非特异性沉淀引起的。对沉淀物的分析表明存在脂蛋白X,这是一种出现在梗阻性黄疸患者或卵磷脂胆固醇酰基转移酶缺乏患者血清中的异常脂蛋白。沉淀剂似乎是聚乙二醇(PEG),在BNA和Array测定法的反应介质中均添加了该物质以稳定Lp(a)-抗Lp(a)免疫复合物。在Array测定法中,通过对稀释样本进行预离心可消除这种非特异性沉淀的干扰。然而,在此步骤中可能会发生Lp(a)的共沉淀。因此,当在含有PEG的介质中使用免疫比浊法时,对肝胆疾病患者血清中Lp(a)测量结果的解释应谨慎。